Can sedation be used for equine lameness investigation?

PICO question In horses undergoing lameness investigation, does sedation with a2-adrenergic agonists alone versus sedation with a2-adrenergic agonists in combination with butorphanol tartrate effect the degree of lameness?   Clinical bottom line Category of research question Diagnosis...

Full description

Bibliographic Details
Main Authors: Helene Termansen, Lucinda Meehan
Format: Article
Language:English
Published: RCVS Knowledge 2021-06-01
Series:Veterinary Evidence
Subjects:
Online Access:https://veterinaryevidence.org/index.php/ve/article/view/373
id doaj-916d317e397e4edb948fb601ebe9d37c
record_format Article
spelling doaj-916d317e397e4edb948fb601ebe9d37c2021-10-05T10:41:06ZengRCVS KnowledgeVeterinary Evidence2396-97762021-06-016210.18849/ve.v6i2.373373Can sedation be used for equine lameness investigation?Helene Termansen0Lucinda Meehan1Langford Veterinary ServicesUniversity of BristolPICO question In horses undergoing lameness investigation, does sedation with a2-adrenergic agonists alone versus sedation with a2-adrenergic agonists in combination with butorphanol tartrate effect the degree of lameness?   Clinical bottom line Category of research question Diagnosis The number and type of study designs reviewed Six papers were critically reviewed. There were two crossover clinical studies, three crossover controlled clinical studies and a randomised controlled clinical study Strength of evidence Moderate Outcomes reported There was limited evidence to suggest that xylazine and romifidine in combination with butorphanol has an effect on forelimb lameness and that detomidine has an effect on hindlimb lameness. Most evidence suggests that xylazine alone or in combination with butorphanol has no effect on the lameness Conclusion In general, sedating a horse with an a2-adrenergic agonist alone or in combination with butorphanol tartrate does not change the baseline degree of lameness. Due to the large variation in the measurements, the small magnitude of few significant effects and the inconsistency of these significant findings, there is insufficient evidence to recommend avoiding the use of sedation in cases where it would increase the safety of those involved. However, regardless of protocol used, clinicians must appreciate the possibility of individual horse variation   How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources. Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.https://veterinaryevidence.org/index.php/ve/article/view/373horsesequinesedationsedativetranquiliserlamenessgait
collection DOAJ
language English
format Article
sources DOAJ
author Helene Termansen
Lucinda Meehan
spellingShingle Helene Termansen
Lucinda Meehan
Can sedation be used for equine lameness investigation?
Veterinary Evidence
horses
equine
sedation
sedative
tranquiliser
lameness
gait
author_facet Helene Termansen
Lucinda Meehan
author_sort Helene Termansen
title Can sedation be used for equine lameness investigation?
title_short Can sedation be used for equine lameness investigation?
title_full Can sedation be used for equine lameness investigation?
title_fullStr Can sedation be used for equine lameness investigation?
title_full_unstemmed Can sedation be used for equine lameness investigation?
title_sort can sedation be used for equine lameness investigation?
publisher RCVS Knowledge
series Veterinary Evidence
issn 2396-9776
publishDate 2021-06-01
description PICO question In horses undergoing lameness investigation, does sedation with a2-adrenergic agonists alone versus sedation with a2-adrenergic agonists in combination with butorphanol tartrate effect the degree of lameness?   Clinical bottom line Category of research question Diagnosis The number and type of study designs reviewed Six papers were critically reviewed. There were two crossover clinical studies, three crossover controlled clinical studies and a randomised controlled clinical study Strength of evidence Moderate Outcomes reported There was limited evidence to suggest that xylazine and romifidine in combination with butorphanol has an effect on forelimb lameness and that detomidine has an effect on hindlimb lameness. Most evidence suggests that xylazine alone or in combination with butorphanol has no effect on the lameness Conclusion In general, sedating a horse with an a2-adrenergic agonist alone or in combination with butorphanol tartrate does not change the baseline degree of lameness. Due to the large variation in the measurements, the small magnitude of few significant effects and the inconsistency of these significant findings, there is insufficient evidence to recommend avoiding the use of sedation in cases where it would increase the safety of those involved. However, regardless of protocol used, clinicians must appreciate the possibility of individual horse variation   How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources. Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
topic horses
equine
sedation
sedative
tranquiliser
lameness
gait
url https://veterinaryevidence.org/index.php/ve/article/view/373
work_keys_str_mv AT helenetermansen cansedationbeusedforequinelamenessinvestigation
AT lucindameehan cansedationbeusedforequinelamenessinvestigation
_version_ 1716843284102381568